|
🐜
|
Blockade of XBP1 splicing by inhibition of IRE1α is a promising therapeutic option in multiple myeloma.
25 auth.
N. Mimura,
M. Fulciniti,
G. Gorgun,
Y. Tai,
D. Cirstea,
L. Santo,
Yiguo Hu,
C. Fabre,
J. Minami,
H. Ohguchi,
T. Kiziltepe,
H. Ikeda,
Y. Kawano,
Maureen French,
M. Blumenthal,
...
Victor L Tam,
N. Kertesz,
U. Malyankar,
M. Hokenson,
T. Pham,
Qingping Zeng,
J. Patterson,
P. Richardson,
N. Munshi,
K. Anderson
|
8 |
2011 |
8
🐜
|
|
🐜
|
Structure and mechanism of action of the hydroxy aryl aldehyde class of IRE1 endoribonuclease inhibitors
23 auth.
M. Sanches,
Nicole M. Duffy,
M. Talukdar,
Neroshan Thevakumaran,
David Chiovitti,
M. Canny,
K. Lee,
I. Kurinov,
D. Uehling,
R. Al-Awar,
...
G. Poda,
M. Prakesch,
Brian J. Wilson,
Victor L Tam,
C. Schweitzer,
A. Toró,
Julie L. Lucas,
D. Vuga,
Lynn W Lehmann,
D. Durocher,
Qingping Zeng,
J. Patterson,
F. Sicheri
|
6 |
2014 |
6
🐜
|
|
🐜
|
Lymph Node–Targeted Immunotherapy Mediates Potent Immunity Resulting in Regression of Isolated or Metastatic Human Papillomavirus–Transformed Tumors
16 auth.
K. Smith,
Brenna L Meisenburg,
Victor L Tam,
Robb R. Pagarigan,
R. Wong,
Diljeet K. Joea,
Liz Lantzy,
Mayra A. Carrillo,
Todd M. Gross,
U. Malyankar,
...
Chih‐Sheng Chiang,
D. D. Da Silva,
T. Kündig,
W. Kast,
Zhiyong Qiu,
A. Bot
|
5 |
2009 |
5
🐜
|
|
🐜
|
Enhancing DNA vaccination by sequential injection of lymph nodes with plasmid vectors and peptides.
12 auth.
K. Smith,
Victor L Tam,
R. Wong,
Robb R. Pagarigan,
Brenna L Meisenburg,
Diljeet K. Joea,
...
Xi-ping Liu,
C. Sanders,
D. Diamond,
T. Kündig,
Zhiyong Qiu,
A. Bot
|
4 |
2009 |
4
🐜
|
|
🐜
|
TLR-9 signaling and TCR stimulation co-regulate CD8(+) T cell-associated PD-1 expression.
9 auth.
R. Wong,
K. Smith,
Victor L Tam,
Robb R. Pagarigan,
Brenna L Meisenburg,
A. Quach,
...
Mayra A. Carrillo,
Zhiyong Qiu,
A. Bot
|
4 |
2009 |
4
🐜
|
|
🐜
|
Structure and mechanism of action of the hydroxy aryl aldehyde class of IRE 1 endoribonuclease inhibitors
23 auth.
M. Sanches,
Nicole M. Duffy,
M. Talukdar,
Neroshan Thevakumaran,
David Chiovitti,
M. Canny,
K. Lee,
I. Kurinov,
D. Uehling,
R. Al-Awar,
...
G. Poda,
M. Prakesch,
Brian J. Wilson,
Victor L Tam,
C. Schweitzer,
A. Toró,
Julie L. Lucas,
D. Vuga,
Lynn W Lehmann,
D. Durocher,
Qingping Zeng,
J. Patterson,
F. Sicheri
|
3 |
2015 |
3
🐜
|
|
🐜
|
Multivalent immunity targeting tumor-associated antigens by intra-lymph node DNA-prime, peptide-boost vaccination
11 auth.
Kent Andrew Smith,
Zhiyong Qiu,
Raymond M. Wong,
Victor L Tam,
B. Tam,
Diljeet K. Joea,
...
A. Quach,
Xiping Liu,
M. Põld,
U. Malyankar,
A. Bot
|
3 |
2011 |
3
🐜
|
|
🐜
|
Targeting IRE1α-XBP1 Pathway Is a Novel Therapeutic Strategy In Multiple Myeloma
15 auth.
N. Mimura,
T. Hideshima,
G. Gorgun,
D. Cirstea,
L. Santo,
Yiguo Hu,
C. Fabre,
M. Blumenthal,
Victor L Tam,
N. Kertesz,
...
Qingping Zeng,
J. Patterson,
N. Munshi,
P. Richardson,
K. Anderson
|
1 |
2010 |
1
🐜
|
|
🐜
|
Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies
23 auth.
A. Ghobadi,
Jack H Landmann,
Alun J. Carter,
M. Cooper,
M. E. Selli,
Jufang Chang,
M. Baker,
C. Miller,
F. Ferraro,
David Y. Chen,
...
Amanda M Smith,
T. Lavalle,
E. Duncavage,
J. Chou,
Victor L Tam,
Joseph M. Benoun,
J. Nater,
N. Scholler,
Francesca Milletti,
R. Vezan,
A. Bot,
J. Rossi,
Nathan Singh
|
1 |
2022 |
1
🐜
|
